BioLineRx Ltd. (NASDAQ:BLRX) PT Set at $4.00 by HC Wainwright Posted by Samantha Guadardo on Aug 13th, 2017 // No Comments
BioLineRx Ltd. logoHC Wainwright set a $4.00 target price on BioLineRx Ltd. (NASDAQ:BLRX) in a research note issued to investors on Wednesday morning. The brokerage currently has a buy rating on the biotechnology company’s stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.